Diagnostics

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus on capturing prescription shares

A suspected rabies case in a buffalo sent panic through a UP village, with hundreds rushing for vaccines after learning funeral raita was made from its milk. But was the fear justified?

Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, genomics-led and precision testing across India

Fitness firm Fittr is moving towards providing a holistic preventive healthcare service, combining diagnostics with doctor consultations, to target non-communicable diseases, according to its founder and CEO Jitendra Chouksey. The firm has earmarked investment of up to Rs 15 crore to set up company-owned diagnostic laboratories in five metro cities, while also collaborating with partners to expand its lab network to 5,000 pin codes across India, Chouksey told PTI. "We are moving towards a preventive healthcare ecosystem, where we are combining diagnostics with doctor consultations, along with coaching and wearable monitoring, to address one of the biggest pain points in the country today, which is the growing number of NCD (non-communicable diseases) deaths, which are happening in the country," he said. Earlier, Fittr operated primarily as a fitness company, where it used to render nutrition and training services with the help of its coaches, he noted. Chouksey was responding to a

India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising demand for proactive health checks and faster genomic diagnostics

India's diagnostic services market is expected to maintain double-digit growth (~12% CAGR) by FY30, driven by rising preventive healthcare awareness and expanding health insurance coverage.

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Innovation fund for deep tech collabs, setting up of labs and 100% deduction on capex under section 35 AD of IT Act among key demands

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Green means trace amounts present. Yellow would indicate a moderate amount. Orange and red are danger indicators. My grandfather's insulin dose was titrated

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

Move was put in place after Delhi saw a fall in sex ratio at birth for 4th straight year, with officials fearing a return of prenatal gender testing

GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes

'Amazon's entry is through a partnership with Orange Health. It is more of a distribution through Amazon'

AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally

Chennai-based Aarthi Scans plans to add 65 new centres by 2030, with 90% in North India, while exploring fitness diagnostics and targeting a Rs 600 crore turnover

With 18 per cent CAGR, India's genomic diagnostics market is expanding into Tier 2 and 3 cities as affordability, cancer screening, and personalised care fuel adoption

Amazon India has launched ‘Amazon Diagnostics’, its new at-home lab test service available via the Amazon app. Integrated into Amazon Medical along with its pharmacy and clinic verticals, the service

Amazon enters India's $15 bn diagnostics sector with at-home test collection, digital reports and integrated health services through Amazon Medical across six cities

Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. No timeline was, however, revealed for the investment rollout. "This collaboration will assist us in expanding our reach and offer high-quality diagnostic services to a large population in eastern India," Suraksha Diagnostics CMD Somnath Chatterjee said. United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres, the company said. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres an